Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope

This publication has 37 references indexed in Scilit:

• Detecting and Measuring Cotranslational Protein Degradation in Vivo
  Science, 2000
• DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
  Annual Review of Immunology, 1999
• Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3
  The Journal of Experimental Medicine, 1999
• The Role of the Hydrophobic Domain in Orienting Natural Signal Sequences within the ER Membrane
  Experimental Cell Research, 1998
• Heads or tails — what determines the orientation of proteins in the membrane
  FEBS Letters, 1995
• The Tumor Protein MAGE-1 Is Located in the Cytosol of Human Melanoma Cells
  Biochemical and Biophysical Research Communications, 1994
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
  The Journal of Experimental Medicine, 1994
• Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
  The Journal of Experimental Medicine, 1994
• Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus.
  The Journal of cell biology, 1988
• Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
  The Journal of Experimental Medicine, 1988